Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Azelon Pharmaceuticals Inc.

www.azelon.com

Latest From Azelon Pharmaceuticals Inc.

Recent Financings of Private Companies (12/2011)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research/analytical instrumentation and reagent sectors.

BioPharmaceutical Medical Device

Azelon receives $4.5M to advance nasal spray teriparatide for osteoporosis

Azelon Pharmaceuticals, formerly Zelos Therapeutics, has secured $4.5 million Series A financing led by Prospect Venture Partners to support the development of the company's ZT-034, a nasal spray formulation of the parathyroid hormone analog teriparatide for the treatment of osteoporosis.

Orthopedics Japan

Recent Financings of Private Companies (10/2011)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

Elevation hopes appointments will lift management team to new high

Elevation Pharmaceuticals, a biopharma company developing aerosol therapies to treat respiratory diseases, has created two new positions: Jaisim Shah joins as senior vice-president and chief business officer, responsible for product positioning and business development; and Dr Pravin Soni becomes senior vice-president and chief technical officer, responsible for all device and drug development activities. Mr Shah was most recently president of Zelos Therapeutics, and Mr Soni was vice-president of product research and development at Alexza Pharmaceuticals.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Zelos Therapeutics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Azelon Pharmaceuticals Inc.
  • Senior Management
  • Joan Lau, PhD, CEO
  • Contact Info
  • Azelon Pharmaceuticals Inc.
    Phone: (610) 260-6045
    200 Barr Harbor Dr., Ste. 400
    West Conshohocken, PA 19428
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register